Skip to content

uniQure NV

US · QURE #2954 by market cap Listed 1970
19.35 -0.88 -4.35%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

About uniQure NV

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

Founded
1998
CEO
Mr. Matthew C. Kapusta
Employees
221
Headquarters
Amsterdam, Noord-Holland, Netherlands (the)
Fiscal year end
12-31
Website
uniqure.com

Company profile

Exchange
US
Symbol
QURE
Market-cap rank
#2954
Listing date
1970-01-01
Market cap
1.36B
Float cap
1.13B
Shares out
70.14M
Float shares
58.29M

Sectors & themes

Biotechnology

Browse all sectors & themes

Quote time 2026-11-20 20:02:37 · For reference only, not investment advice and not tailored to your situation.

uniQure NV discussion 0 comments

Add a comment